Editorial: California shouldn’t keep DNA from hundreds of thousands of innocent people
By Chronicle Editorial Board,
San Francisco Chronicle [cites CGS' Marcy Darnovsky]
| 12. 14. 2018
California is being sued over its DNA collection practices, and the only thing that’s surprising is how long it took. In 2004, state voters passed Proposition 69, which requires authorities to collect DNA from anyone arrested for a felony. The person’s DNA profile is then uploaded to the national Combined DNA Index System.
Police and other law enforcement agencies around the country love the database, because it allows them to share information, generate leads, and connect the dots between crimes.
These are important functions, and DNA databases have been a breakthrough tool for law enforcement. In California, police agencies have used DNA databases to find the perpetrators of horrific crimes like the Gypsy Hill Killings.
But as we pointed out in 2004, there’s always been one huge flaw with Prop. 69: the size of the net it casts.
Prop. 69 requires DNA collection for anyone who’s been arrested for a felony, not convicted of a felony.
What that effectively means is that law enforcement agencies are allowed to keep the genetic profiles of thousands of people who have...
Related Articles
By Rob Stein, NPR | 04.23.2026
The Food and Drug Administration approved the first gene therapy to restore hearing for people who were born deaf.
The decision, while only immediately affecting people born with a very rare form of genetic deafness, is being hailed as...
By Alfonso Martinez Arias, Nicolas Rivron, and Naomi Moris, BioNews | 04.20.2026
By George Janes, BioNews | 04.20.2026
New regulations in sperm donation are being implemented by Belgium's Federal Agency for Medicines and Health Products (FAMHP), following revelations regarding the use of sperm carrying a cancer-causing mutation, and widespread breaches of donor limits.
In 2025, it...
By Sriparna Roy, Reuters | 04.23.2026
The U.S. Food and Drug Administration has approved Regeneron’s gene therapy for a rare genetic form of deafness, the company said on Thursday.
This approval, granted under the FDA’s new priority voucher program, marks the introduction of the first gene...